Surgical Stabilization of Rib Fractures in Severe Polytrauma: A Potential Indication

Area of Science:

• Trauma Surgery
• Critical Care Medicine
• Thoracic Surgery

Background:

• Surgical stabilization of rib fractures (SSRF) efficacy is primarily studied in isolated chest injuries.
• Emerging data suggests SSRF may benefit polytrauma patients, reducing mortality.
• This study investigates SSRF outcomes specifically in severe polytrauma patients.

Purpose of the Study:

• To evaluate the impact of SSRF on mortality, pneumonia, ARDS, and mechanical ventilation duration.
• To analyze SSRF outcomes in a large cohort of severe polytrauma patients.
• To determine if SSRF offers benefits beyond isolated chest trauma.

Main Methods:

• Utilized the 2013-2021 Trauma Quality Improvement Project database.
• Included severe polytrauma patients (ISS ≥15, AIS ≥2 in ≥2 regions) with rib fractures.
• Employed inverse probability of treatment weighting, Poisson, and quantile regression models for analysis.

Main Results:

• SSRF (1.3% of cohort) was linked to a 57% reduction in mortality and 53% lower ARDS risk (P < 0.001).
• SSRF decreased mechanical ventilation duration by approximately 1 day (P < 0.001).
• A 55% lower pneumonia rate was observed with SSRF in patients with ISS 15-19 (P = 0.023).

Conclusions:

• Early SSRF (within 72 hours) in severe polytrauma patients improves survival and reduces ARDS.
• SSRF is associated with shorter mechanical ventilation, indicating improved respiratory recovery.
• Pneumonia reduction with SSRF was specific to patients with moderate injury severity (ISS 15-19).